Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SILICON LABORATORIES INC. Director's Dealing 2012

May 2, 2012

31118_dirs_2012-05-02_227b57c8-357a-40b6-bc64-9b30ff4885a5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: SILICON LABORATORIES INC (SLAB)
CIK: 0001038074
Period of Report: 2012-04-27

Reporting Person: BRESEMANN DAVID P (Sr Vice President, Vertical)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, $0.0001 par value 67257 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (right to buy) $33.17 2014-08-10 Common Stock, $0.0001 par value (1667) Direct
Non-Qualified Stock Option (right to buy) $36.81 2015-12-19 Common Stock, $0.0001 par value (3710) Direct
Non-Qualified Stock Option (right to buy) $32.11 2017-02-15 Common Stock, $0.0001 par value (11334) Direct
Non-Qualified Stock Option (right to buy) $31.96 2018-02-15 Common Stock, $0.0001 par value (15053) Direct

Footnotes

F1: Includes 27,464 restricted stock units (RSUs) that will entitle Reporting Person to receive one share of common stock per RSU. 12,881 RSUs will vest on February 15, 2013, 8,747 RSUs will vest on February 15, 2014, and 5,836 RSUs will vest on February 15, 2015. All RSUs will be settled pursuant to the Issuer's 2009 Stock Incentive Plan.

F2: Option vests and becomes exercisable with respect to (i) twenty percent (20%) of the option shares upon the date exercisable and (ii) the balance of the option shares in a series of forty-eight (48) successive monthly installments over the forty-eight (48) month period measured from the date exercisable.

F3: Option vests and becomes exercisable with respect to (i) twenty-five percent (25%) of the option shares upon the date exercisable and (ii) the balance of the option shares in a series of thirty-six (36) successive monthly installments over the thirty-six (36) month period measured from the date exercisable.